查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1550062

心臟瓣膜修復·置换市场:全球产业分析，规模，占有率，成长，趋势，预测，2024年～2031年

Heart Valve Repair and Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 308 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球心臟瓣膜修復和置换市场的详细研究报告。该报告提供了对市场结构的全面了解，并对关键市场动态进行了详细评估，包括推动因素、趋势、机会和挑战。

主要观察

  • 心臟瓣膜修復与置换市场规模（2024 年）：85.0634 亿美元
  • 市场预测金额（2031 年）：16,968,010,000 美元
  • 全球市场成长率（2024-2031 年复合年增长率）：10.4%

心臟瓣膜修復更换市场 - 报告范围：

心臟瓣膜修復和置换市场专注于用于修復或置换受损心臟瓣膜并确保血液正常流经心臟的设备和技术。心臟病患病率上升、人口老化以及微创手术技术的进步推动了市场成长。这些因素促使全球对心臟瓣膜修復和置换手术的需求不断增长。

推动市场成长的因素：

全球心臟瓣膜修復和置换市场受到几个关键因素的推动，包括主动脉瓣狭窄和风湿性心臟病等心臟病盛行率的上升。这些疾病的盛行率不断上升，特别是在老年人中，刺激了对心臟瓣膜修復和置换的需求。此外，医疗保健系统正在迅速发展，医疗保健提供者采用新技术，透过更好的治疗、药物和疗法来改善患者护理。政府支持改善医疗保健、有利的报销政策和灵活的保险索赔的措施也有助于市场成长。在心臟瓣膜开发中越来越多地使用数据驱动技术也是一个主要驱动力。製造商正在利用医院数据并实施物联网和人工智慧等先进技术来设计智慧、高品质的心臟瓣膜。这些技术的采用预计将透过提高心臟瓣膜修復和置换手术的精确度和有效性来推动未来几年的市场成长。

市场阻碍因素：

儘管心臟瓣膜修復和置换市场具有巨大的成长潜力，但仍面临一些挑战。主要阻碍因素之一是心臟瓣膜置换术的相关风险。心臟瓣膜置换术是侵入性的，具有重大风险，包括过度出血、心律不整、中风、肾臟损伤和感染。儘管微创技术风险较低，但由于与传统侵入性手术相比成本相对较高，一些患者可能会犹豫是否选择手术。这些风险和成本可能会影响市场成长，特别是在获得先进医疗服务的机会有限的地区。

市场机会：

由于医疗基础设施的进步和微创手术的采用增加，心臟瓣膜修復和置换市场提供了巨大的成长机会。人们对心血管疾病的认识不断提高以及先进治疗方案的可用性预计将推动心臟瓣膜修復和置换的需求。此外，瓣膜设计的持续创新和数据驱动技术的整合预计将为市场参与者提供开发下一代心臟瓣膜的新机会，从而改善患者的治疗效果并降低风险。

本报告解决的关键问题

  • 推动全球心臟瓣膜修復和置换市场成长的关键因素有哪些？
  • 哪些类型的心臟瓣膜和手术技术正在推动各种医疗机构的需求？
  • 技术进步如何影响心臟瓣膜修復与置换市场的竞争格局？
  • 谁是心臟瓣膜修復和置换市场的主要参与者？
  • 全球心臟瓣膜修復与置换市场的新趋势与未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势
  • 法规情势

第4章 主要成功因素

  • 退还情势
  • 心臟瓣膜手术统计，2019年

第5章 全球心臟瓣膜修復·置换市场 - 价格分析

  • 各国价格分析:各产品类型
  • 价格的明细
    • 厂商层级的价格设定
    • 分销商层级的价格设定
  • 世界平均价格分析基准

第6章 世界经济预测

  • 国内生产总值:各地区·各国(2019年～2023年)
  • 全球医疗保健市场展望

第7章 全球心臟瓣膜修復·置换市场需求(金额，一百万美元)分析

  • 过去的市场金额(一百万美元)分析，2019年～2023年
  • 现在及未来市场金额(一百万美元)预测，2024年～2031年
    • 前一年同期比较成长趋势分析
    • 绝对额的机会分析

第8章 市场背景

  • 宏观经济要素
  • 预测要素 - 相关性及影响
  • 价值链
  • 市场动态

第9章 全球心臟瓣膜修復·置换市场分析，各产品类型

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析，各产品类型，2019年～2023年
  • 现在及未来市场规模(一百万美元)分析与预测，各产品类型，2024年～2031年
    • 心臟瓣膜修復
    • 心臟瓣膜置换
  • 市场魅力分析:各产品类型

第10章 全球心臟瓣膜修復·置换市场分析，各疾病适应症

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析，各疾病适应症，2019年～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测，各疾病适应症，2024年～2031年
    • 主动脉瓣膜狭窄症
    • 主动脉瓣膜逆流症
    • 二尖瓣狭窄症
    • 二尖瓣逆流症
  • 市场魅力分析:各疾病适应症

第11章 全球心臟瓣膜修復·替换市场分析，各终端用户

  • 简介/主要调查结果
  • 过去的市场规模(一百万美元)的分析，各终端用户，2019年～2023年
  • 现在及未来市场规模(一百万美元)的分析与预测，各终端用户，2024年～2031年
    • 医院
    • 门诊病人手术中心
    • 心导管检验室
  • 市场魅力分析:各终端用户

第12章 全球心臟瓣膜修復·置换市场分析，各地区

  • 简介
  • 过去的市场规模(一百万美元)的分析，各地区，2019年～2023年
  • 现在及未来市场规模(一百万美元)分析与预测，各地区，2024年～2031年
    • 北美
    • 南美
    • 欧洲
    • 中东·非洲(MEA)
    • 东亚
    • 南亚
    • 大洋洲
  • 市场魅力分析:各地区

第13章 北美的心臟瓣膜修復·置换市场分析

第14章 南美的心臟瓣膜修復·置换市场分析

第15章 欧洲的心臟瓣膜修復·置换市场分析

第16章 南亚的心臟瓣膜修復·置换市场分析

第17章 东亚的心臟瓣膜修復·置换市场分析

第18章 大洋洲的心臟瓣膜修復·置换市场分析

第19章 中东·非洲的心臟瓣膜修復·置换市场分析

第20章 新兴国家的心臟瓣膜修復·置换市场分析

  • 简介
    • 市场金额比较起来分析:各主要国家
    • 世界 Vs. 各国成长比较
  • 中国心臟瓣膜修復·置换市场分析
    • 简介
    • 市场金额比较起来分析:市场各分类
    • 市场金额(一百万美元)分析与预测:市场各分类
    • 中国的心臟瓣膜修復·置换市场 - 竞争情形
  • 日本的心臟瓣膜修復·置换市场分析
    • 简介
    • 市场金额比较起来分析:市场各分类
    • 市场金额(一百万美元)分析与预测:市场各分类
    • 日本的心臟瓣膜修復·置换市场 - 竞争情形
  • 印度的心臟瓣膜修復·置换市场分析
    • 简介
    • 市场金额比较起来分析:市场各分类
    • 市场金额(一百万美元)分析与预测:市场各分类
    • 印度的心臟瓣膜修復·置换市场 - 竞争情形

第21章 市场结构分析

  • 市场分析:各企业等级(心臟瓣膜修復·置换)
  • 市场集中
  • 主要企业的市场占有率分析
  • 市场影响分析

第22章 竞争分析

  • 竞争仪表板
  • 竞争的详细资讯
    • Medtronic
    • Abbott
    • Edwards Lifesciences Corporation
    • Boston Scientific Corporation
    • CryoLife, Inc.
    • LivaNova PLC
    • Colibri Heart Valve
    • JenaValve Technology, Inc.
    • Micro Interventional Devices, Inc.
    • Braile Biomedica
    • Arbor Surgical Technologies, Inc.
    • Aortech International Plc

第23章 所使用的前提条件与缩写

第24章 调查手法

简介目录
Product Code: PMRREP3192

Persistence Market Research has recently released a detailed report on the global heart valve repair and replacement market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

  • Heart Valve Repair and Replacement Market Size (2024E): US$ 8506.34 Mn
  • Projected Market Value (2031F): US$ 16968.01 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 10.4%

Heart Valve Repair & Replacement Market - Report Scope:

The heart valve repair and replacement market focuses on devices and technologies used to repair or replace damaged heart valves, ensuring the proper flow of blood through the heart. The market growth is driven by the rising prevalence of cardiac disorders, the aging population, and advancements in minimally invasive surgical techniques. These factors are contributing to the increasing demand for heart valve repair and replacement procedures globally.

Market Growth Drivers:

The global heart valve repair and replacement market is driven by several key factors, including the rising prevalence of cardiac disorders such as aortic stenosis and rheumatic heart disease. The growing incidence of these conditions, particularly among the elderly, is fueling the demand for heart valve repair and replacement. Additionally, the healthcare system is rapidly evolving, with institutions adopting new technologies and improving patient care through better treatments, medications, and therapies. Government initiatives supporting healthcare improvements, along with favorable reimbursement policies and flexible insurance claims, are also contributing to market growth. Another significant driver is the increased usage of data-driven technologies in developing heart valves. Manufacturers are leveraging hospital data and implementing advanced technologies such as IoT and artificial intelligence to design smart, high-quality heart valves. The adoption of these technologies is expected to drive market growth in the coming years by enhancing the precision and effectiveness of heart valve repair and replacement procedures.

Market Restraints:

Despite the strong growth potential, the heart valve repair and replacement market faces several challenges. One of the primary restraints is the risk associated with heart valve replacement procedures, which are invasive and carry significant risks such as excessive bleeding, arrhythmia, stroke, renal issues, and infections. Although minimally invasive techniques offer lower risks, the cost of these procedures is relatively high compared to traditional invasive surgery, which can deter some patients from opting for surgery. These risks and costs are likely to impact the market's growth, particularly in regions with limited access to advanced healthcare services.

Market Opportunities:

The heart valve repair and replacement market presents substantial growth opportunities driven by advancements in healthcare infrastructure and the increasing adoption of minimally invasive procedures. The growing awareness of cardiovascular diseases and the availability of advanced treatment options are expected to boost the demand for heart valve repair and replacement. Additionally, continuous innovations in valve design and the integration of data-driven technologies will create new opportunities for market players to develop next-generation heart valves that offer improved outcomes and reduced risks for patients.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the heart valve repair and replacement market globally?
  • Which types of heart valves and surgical techniques are leading the demand in various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the heart valve repair and replacement market?
  • Who are the key players in the heart valve repair and replacement market, and what strategies are they employing to enhance their market presence?
  • What are the emerging trends and future prospects in the global heart valve repair and replacement market?

Competitive Intelligence and Business Strategy:

Leading players in the global heart valve repair and replacement market, including companies such as Edwards Lifesciences, Medtronic, and Abbott Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced heart valve technologies, such as transcatheter aortic valve replacement (TAVR) and minimally invasive mitral valve repair. Collaborations with hospitals and research institutions facilitate the adoption of these technologies and improve patient outcomes. Emphasis on data-driven innovation, cost-effective solutions, and expanding access to advanced surgical options drives growth and strengthens market positioning in the dynamic heart valve repair and replacement industry.

Key Companies Profiled:

  • Medtronic
  • Abbott
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • LivaNova PLC
  • Colibri Heart Valve
  • JenaValve Technology, Inc.
  • Micro Interventional Devices, Inc.
  • Braile Biomedica
  • Arbor Surgical Technologies, Inc.
  • Aortech International Plc

Heart Valve Repair Replacement Market Categorization

Heart Valve Repair Replacement Market by By Product

  • Heart Valve Repair
  • Heart Valve Replacement
  • Tissue Heart Valves
  • Transcatheter Aortic Valve Implantation (TAVI)

Heart Valve Repair Replacement Market By Indication

  • Aortic Stenosis
  • Aortic Regurgitation
  • Mitral Stenosis
  • Mitral Regurgitation

Heart Valve Repair Replacement Market By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

Heart Valve Repair Replacement Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends
  • 3.3. Regulatory Scenario

4. Key Success Factors

  • 4.1. Reimbursement Scenario
  • 4.2. Heart Valve Procedure Statistics, 2019

5. Global Heart Valve Repair and Replacement Market - Pricing Analysis

  • 5.1. Country Pricing Analysis By Product Type
  • 5.2. Pricing Break-up
    • 5.2.1. Manufacturer Level Pricing
    • 5.2.2. Distributor Level Pricing
  • 5.3. Global Average Pricing Analysis Benchmark

6. Global Economic Outlook

  • 6.1. Gross Domestic Product by Region & Country, 2019-2023
  • 6.2. Global Healthcare Market Outlook

7. Global Heart Valve Repair and Replacement Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Healthcare Expenditure by Country
    • 8.1.3. Regional Healthcare Market Outlook
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Development and commercialization of heart valve therapies
    • 8.2.2. Increasing incidence of congenital heart defects
    • 8.2.3. Rise in geriatric population with structural heart disorders
    • 8.2.4. Varied stringency of regulatory procedures
    • 8.2.5. High costs associated with heart valve repair and replacement procedures
  • 8.3. Value Chain
  • 8.4. Market Dynamics
    • 8.4.1. Drivers
    • 8.4.2. Restraints
    • 8.4.3. Opportunity Analysis

9. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
    • 9.3.1. Heart Valve Repair
      • 9.3.1.1. Mitral Valve Annuloplasty Rings
      • 9.3.1.2. Transcatheter Mitral Valve Repair (TMVR)
    • 9.3.2. Heart Valve Replacement
      • 9.3.2.1. Mechanical Heart Valves
        • 9.3.2.1.1. Mechanical Sutured Aortic Valve Replacements
        • 9.3.2.1.2. Mechanical Sutured Mitral Valve Replacements
      • 9.3.2.2. Tissue Heart Valves
        • 9.3.2.2.1. Tissue Sutured Aortic Valve Replacements
        • 9.3.2.2.2. Tissue Sutured Mitral Valve Replacements
        • 9.3.2.2.3. Tissue Sutureless Aortic Valve Replacements
      • 9.3.2.3. Transcatheter Aortic Valve Implantation (TAVI)
  • 9.4. Market Attractiveness Analysis By Product Type

10. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Disease Indication

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2024-2031
    • 10.3.1. Aortic Stenosis
    • 10.3.2. Aortic Regurgitation
    • 10.3.3. Mitral Stenosis
    • 10.3.4. Mitral Regurgitation
  • 10.4. Market Attractiveness Analysis By Disease Indication

11. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 11.3.1. Hospitals
    • 11.3.2. Ambulatory Surgical Centers
    • 11.3.3. Cardiac Catheterization Laboratories
  • 11.4. Market Attractiveness Analysis By End User

12. Global Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. Middle East and Africa (MEA)
    • 12.3.5. East Asia
    • 12.3.6. South Asia
    • 12.3.7. Oceania
  • 12.4. Market Attractiveness Analysis By Region

13. North America Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.4.1. By Country
      • 13.4.1.1. U.S.
      • 13.4.1.2. Canada
    • 13.4.2. By Product Type
    • 13.4.3. By Disease Indication
    • 13.4.4. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Disease Indication
    • 13.5.4. By End User
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis

14. Latin America Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. Brazil
      • 14.4.1.2. Mexico
      • 14.4.1.3. Rest of Latin America
    • 14.4.2. By Product Type
    • 14.4.3. By Disease Indication
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Disease Indication
    • 14.5.4. By End User
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis

15. Europe Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Germany
      • 15.4.1.2. Italy
      • 15.4.1.3. France
      • 15.4.1.4. U.K.
      • 15.4.1.5. Spain
      • 15.4.1.6. BENELUX
      • 15.4.1.7. Russia
      • 15.4.1.8. Rest of Europe
    • 15.4.2. By Product Type
    • 15.4.3. By Disease Indication
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Disease Indication
    • 15.5.4. By End User
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis

16. South Asia Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. India
      • 16.4.1.2. Thailand
      • 16.4.1.3. Indonesia
      • 16.4.1.4. Malaysia
      • 16.4.1.5. Rest of South Asia
    • 16.4.2. By Product Type
    • 16.4.3. By Disease Indication
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Disease Indication
    • 16.5.4. By End User
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis

17. East Asia Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. China
      • 17.4.1.2. Japan
      • 17.4.1.3. South Korea
    • 17.4.2. By Product Type
    • 17.4.3. By Disease Indication
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product Type
    • 17.5.3. By Disease Indication
    • 17.5.4. By End User
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis

18. Oceania Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. Australia
      • 18.4.1.2. New Zealand
    • 18.4.2. By Product Type
    • 18.4.3. By Disease Indication
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product Type
    • 18.5.3. By Disease Indication
    • 18.5.4. By End User
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 19.4.1. By Country
      • 19.4.1.1. GCC Countries
      • 19.4.1.2. Northern Africa
      • 19.4.1.3. South Africa
      • 19.4.1.4. Rest of Middle East and Africa
    • 19.4.2. By Product Type
    • 19.4.3. By Disease Indication
    • 19.4.4. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Product Type
    • 19.5.3. By Disease Indication
    • 19.5.4. By End User
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis

20. Emerging Countries Heart Valve Repair and Replacement Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
    • 20.1.1. Market Value Proportion Analysis, By Key Countries
    • 20.1.2. Global Vs. Country Growth Comparison
  • 20.2. China Heart Valve Repair and Replacement Market Analysis
    • 20.2.1. Introduction
    • 20.2.2. Market Value Proportion Analysis by Market Taxonomy
    • 20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 20.2.3.1. By Product Type
      • 20.2.3.2. By Disease Indication
      • 20.2.3.3. By End User
    • 20.2.4. China Heart Valve Repair and Replacement Market - Competition Landscape
  • 20.3. Japan Heart Valve Repair and Replacement Market Analysis
    • 20.3.1. Introduction
    • 20.3.2. Market Value Proportion Analysis by Market Taxonomy
    • 20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 20.3.3.1. By Product Type
      • 20.3.3.2. By Disease Indication
      • 20.3.3.3. By End User
    • 20.3.4. Japan Heart Valve Repair and Replacement Market - Competition Landscape
  • 20.4. India Heart Valve Repair and Replacement Market Analysis
    • 20.4.1. Introduction
    • 20.4.2. Market Value Proportion Analysis by Market Taxonomy
    • 20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 20.4.3.1. By Product Type
      • 20.4.3.2. By Disease Indication
      • 20.4.3.3. By End User
    • 20.4.4. India Heart Valve Repair and Replacement Market - Competition Landscape

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies (Heart Valve Repair and Replacement)
  • 21.2. Market Concentration
  • 21.3. Market Share Analysis of Top Players
  • 21.4. Market Presence Analysis
    • 21.4.1. By Regional footprint of Players
    • 21.4.2. Product foot print by Players
    • 21.4.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Medtronic
      • 22.2.1.1. Overview
      • 22.2.1.2. Product Portfolio
      • 22.2.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.1.4. Sales Footprint
      • 22.2.1.5. Strategy Overview
        • 22.2.1.5.1. Marketing Strategy
        • 22.2.1.5.2. Product Strategy
        • 22.2.1.5.3. Channel Strategy
    • 22.2.2. Abbott
      • 22.2.2.1. Overview
      • 22.2.2.2. Product Portfolio
      • 22.2.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.2.4. Sales Footprint
      • 22.2.2.5. Strategy Overview
        • 22.2.2.5.1. Marketing Strategy
        • 22.2.2.5.2. Product Strategy
        • 22.2.2.5.3. Channel Strategy
    • 22.2.3. Edwards Lifesciences Corporation
      • 22.2.3.1. Overview
      • 22.2.3.2. Product Portfolio
      • 22.2.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.3.4. Sales Footprint
      • 22.2.3.5. Strategy Overview
        • 22.2.3.5.1. Marketing Strategy
        • 22.2.3.5.2. Product Strategy
        • 22.2.3.5.3. Channel Strategy
    • 22.2.4. Boston Scientific Corporation
      • 22.2.4.1. Overview
      • 22.2.4.2. Product Portfolio
      • 22.2.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.4.4. Sales Footprint
      • 22.2.4.5. Strategy Overview
        • 22.2.4.5.1. Marketing Strategy
        • 22.2.4.5.2. Product Strategy
        • 22.2.4.5.3. Channel Strategy
    • 22.2.5. CryoLife, Inc.
      • 22.2.5.1. Overview
      • 22.2.5.2. Product Portfolio
      • 22.2.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.5.4. Sales Footprint
      • 22.2.5.5. Strategy Overview
        • 22.2.5.5.1. Marketing Strategy
        • 22.2.5.5.2. Product Strategy
        • 22.2.5.5.3. Channel Strategy
    • 22.2.6. LivaNova PLC
      • 22.2.6.1. Overview
      • 22.2.6.2. Product Portfolio
      • 22.2.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.6.4. Sales Footprint
      • 22.2.6.5. Strategy Overview
        • 22.2.6.5.1. Marketing Strategy
        • 22.2.6.5.2. Product Strategy
        • 22.2.6.5.3. Channel Strategy
    • 22.2.7. Colibri Heart Valve
      • 22.2.7.1. Overview
      • 22.2.7.2. Product Portfolio
      • 22.2.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.7.4. Sales Footprint
      • 22.2.7.5. Strategy Overview
        • 22.2.7.5.1. Marketing Strategy
        • 22.2.7.5.2. Product Strategy
        • 22.2.7.5.3. Channel Strategy
    • 22.2.8. JenaValve Technology, Inc.
      • 22.2.8.1. Overview
      • 22.2.8.2. Product Portfolio
      • 22.2.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.8.4. Sales Footprint
      • 22.2.8.5. Strategy Overview
        • 22.2.8.5.1. Marketing Strategy
        • 22.2.8.5.2. Product Strategy
        • 22.2.8.5.3. Channel Strategy
    • 22.2.9. Micro Interventional Devices, Inc.
      • 22.2.9.1. Overview
      • 22.2.9.2. Product Portfolio
      • 22.2.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.9.4. Sales Footprint
      • 22.2.9.5. Strategy Overview
        • 22.2.9.5.1. Marketing Strategy
        • 22.2.9.5.2. Product Strategy
        • 22.2.9.5.3. Channel Strategy
    • 22.2.10. Braile Biomedica
      • 22.2.10.1. Overview
      • 22.2.10.2. Product Portfolio
      • 22.2.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.10.4. Sales Footprint
      • 22.2.10.5. Strategy Overview
        • 22.2.10.5.1. Marketing Strategy
        • 22.2.10.5.2. Product Strategy
        • 22.2.10.5.3. Channel Strategy
    • 22.2.11. Arbor Surgical Technologies, Inc.
      • 22.2.11.1. Overview
      • 22.2.11.2. Product Portfolio
      • 22.2.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.11.4. Sales Footprint
      • 22.2.11.5. Strategy Overview
        • 22.2.11.5.1. Marketing Strategy
        • 22.2.11.5.2. Product Strategy
        • 22.2.11.5.3. Channel Strategy
    • 22.2.12. Aortech International Plc
      • 22.2.12.1. Overview
      • 22.2.12.2. Product Portfolio
      • 22.2.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.2.12.4. Sales Footprint
      • 22.2.12.5. Strategy Overview
        • 22.2.12.5.1. Marketing Strategy
        • 22.2.12.5.2. Product Strategy
        • 22.2.12.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology